These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37509170)

  • 21. [
    Nock BA; Kaloudi A; Kanellopoulos P; Janota B; Bromińska B; Iżycki D; Mikołajczak R; Czepczynski R; Maina T
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I Trial of [
    Chernov V; Rybina A; Zelchan R; Medvedeva A; Bragina O; Lushnikova N; Doroshenko A; Usynin E; Tashireva L; Vtorushin S; Abouzayed A; Rinne SS; Sörensen J; Tolmachev V; Orlova A
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of the new GRPR-antagonist
    Lymperis E; Kaloudi A; Kanellopoulos P; Krenning EP; de Jong M; Maina T; Nock BA
    J Labelled Comp Radiopharm; 2019 Aug; 62(10):646-655. PubMed ID: 30963606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The GRPR Antagonist [
    Abouzayed A; Borin J; Lundmark F; Rybina A; Hober S; Zelchan R; Tolmachev V; Chernov V; Orlova A
    Diagnostics (Basel); 2023 May; 13(9):. PubMed ID: 37175001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.
    Maina T; Kaloudi A; Valverde IE; Mindt TL; Nock BA
    Nucl Med Biol; 2017 Sep; 52():57-62. PubMed ID: 28636973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.
    Abiraj K; Mansi R; Tamma ML; Fani M; Forrer F; Nicolas G; Cescato R; Reubi JC; Maecke HR
    J Nucl Med; 2011 Dec; 52(12):1970-8. PubMed ID: 22080443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET Using a GRPR Antagonist
    Zhang J; Niu G; Fan X; Lang L; Hou G; Chen L; Wu H; Zhu Z; Li F; Chen X
    J Nucl Med; 2018 Jun; 59(6):922-928. PubMed ID: 29123014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing Gly
    Lymperis E; Kaloudi A; Kanellopoulos P; de Jong M; Krenning EP; Nock BA; Maina T
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30871262
    [No Abstract]   [Full Text] [Related]  

  • 30. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
    Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
    J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [
    Vats K; Chakraborty A; Rakshit S; Damle A; Sarma HD; Satpati D
    Nucl Med Biol; 2023; 118-119():108331. PubMed ID: 36933456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, radiolabeling, and evaluation of gastrin releasing peptide receptor antagonist
    Satpati D; Vats K; Sharma R; Kameswaran M; Sarma HD; Dash A
    J Labelled Comp Radiopharm; 2019 Oct; 62(12):843-849. PubMed ID: 31378967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substitution of l-Tryptophan by
    Günther T; Deiser S; Felber V; Beck R; Wester HJ
    J Nucl Med; 2022 Sep; 63(9):1364-1370. PubMed ID: 35027371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.
    Marsouvanidis PJ; Maina T; Sallegger W; Krenning EP; de Jong M; Nock BA
    J Nucl Med; 2013 Oct; 54(10):1797-803. PubMed ID: 24009275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copper-64 Labeled Macrobicyclic Sarcophagine Coupled to a GRP Receptor Antagonist Shows Great Promise for PET Imaging of Prostate Cancer.
    Gourni E; Del Pozzo L; Kheirallah E; Smerling C; Waser B; Reubi JC; Paterson BM; Donnelly PS; Meyer PT; Maecke HR
    Mol Pharm; 2015 Aug; 12(8):2781-90. PubMed ID: 26132879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin.
    Lymperis E; Kaloudi A; Sallegger W; Bakker IL; Krenning EP; de Jong M; Maina T; Nock BA
    Bioconjug Chem; 2018 May; 29(5):1774-1784. PubMed ID: 29664606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer.
    Abouzayed A; Tano H; Nagy Á; Rinne SS; Wadeea F; Kumar S; Westerlund K; Tolmachev V; Eriksson Karlström A; Orlova A
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33081166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
    Dalm SU; Bakker IL; de Blois E; Doeswijk GN; Konijnenberg MW; Orlandi F; Barbato D; Tedesco M; Maina T; Nock BA; de Jong M
    J Nucl Med; 2017 Feb; 58(2):293-299. PubMed ID: 27609789
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.